4-[4-(1-Ethyl-6-methyl-1,2,3,6-tetrahydropyridin-4-yl)-2-(4-fluorophenyl)-1H-pyrrol-3-yl]pyridine

ID: ALA1091626

PubChem CID: 9820331

Max Phase: Preclinical

Molecular Formula: C23H24FN3

Molecular Weight: 361.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN1CCC(c2c[nH]c(-c3ccc(F)cc3)c2-c2ccncc2)=CC1C

Standard InChI:  InChI=1S/C23H24FN3/c1-3-27-13-10-19(14-16(27)2)21-15-26-23(18-4-6-20(24)7-5-18)22(21)17-8-11-25-12-9-17/h4-9,11-12,14-16,26H,3,10,13H2,1-2H3

Standard InChI Key:  ASPRKFLJNYTNON-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   12.1503  -25.1415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8319  -25.6049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4832  -25.0999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2042  -24.3241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3803  -24.3504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9593  -23.6434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3660  -22.9235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9460  -22.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1194  -22.2220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7146  -22.9466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1369  -23.6538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4392  -25.5582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7210  -25.1483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0091  -25.5652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0141  -26.3919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7370  -26.7998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4460  -26.3806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6230  -23.6113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4497  -23.6165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8653  -22.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4587  -22.1879    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6319  -22.1827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2118  -22.8967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3023  -26.8105    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.8770  -21.4759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6910  -22.9134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7028  -21.4822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  2  0
 13 14  1  0
  2  3  1  0
 14 15  2  0
  7  8  1  0
 15 16  1  0
  3  4  2  0
 16 17  2  0
 17 12  1  0
  1 12  1  0
 18 19  2  0
  8  9  2  0
  4  5  1  0
  9 10  1  0
  5  1  2  0
 10 11  2  0
 11  6  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  4 18  1  0
  5  6  1  0
 15 24  1  0
  1  2  1  0
 21 25  1  0
 20 26  1  0
 12 13  2  0
 25 27  1  0
M  END

Associated Targets(Human)

Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.46Molecular Weight (Monoisotopic): 361.1954AlogP: 5.38#Rotatable Bonds: 4
Polar Surface Area: 31.92Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.24CX LogP: 4.34CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -0.33

References

1. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K..  (2010)  Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2.,  20  (8): [PMID:20346666] [10.1016/j.bmcl.2010.03.022]
2. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K..  (2010)  Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 3.,  20  (16): [PMID:20637613] [10.1016/j.bmcl.2010.06.122]

Source